Insulin Chinese Description

Generic Name: Low Protamine Recombinant Human Insulin Injection Product Name: Gan Shulin N Drug Category: Biological Products Drug Properties: Prescription Drug Related Diseases: Diabetes, Traits: This product is a white or white-like sterile suspension liquid, which can be evenly shaken. dispersion. Main ingredients: The active ingredient of this product is: recombinant human insulin. Indications: This product is mainly used to treat type I or type II diabetes. Specifications: 3 ml / 300 units / refill adverse reactions: reported in the literature occasional injection of local redness, itching and other allergies should be local subcutaneous lipid proliferation. Systemic allergic reactions (systemic rash, shortness of breath, asthma, decreased blood pressure, rapid pulse, hyperhidrosis, severe life-threatening cases) are rarely reported. 1. Lipid dystrophy, subcutaneous injection of insulin rarely causes lipid atrophy or lipid proliferation. If this happens, you must inform your doctor. Changing injection techniques may improve this. 2. Insulin allergy, (1) local allergic reactions. Occasionally, the patient's injection site is red and swollen, which is called local allergy. It usually disappears within a few days or weeks. In some cases, it may be caused by other causes and has nothing to do with insulin injection. If the skin disinfectant is irritated, the injection technique is not good, etc., if a local reaction occurs, immediately inform the doctor. Dosage: How to use: 1. This product is white or off-white suspension. It is injected subcutaneously about 1 hour before breakfast and dinner. The specific time is determined by the doctor according to the patient's condition. 2. Method of preparing insulin: first wash your hands, gently shake or turn the medicine bottle to mix the liquid evenly, and carefully check the appearance of the insulin taken, remove the plastic protective cap, expose the rubber stopper, use 75% alcohol Wipe the stopper, if using one type of insulin, inhale the syringe into the air equivalent to the insulin dose, insert the needle into the stopper, inject the air into the tube, invert the syringe and the vial, hold it with one hand and gently shake it. Make sure the top of the injection needle is below the liquid level and then use the other hand to push the pusher backwards to extract the correct amount. Before withdrawing the needle, check the needle tube for bubbles. If there are air bubbles, the needle should be contraindicated: History of insulin allergy Disabled. Precautions: 1. Diabetes patients should check blood sugar or urine sugar regularly. If blood glucose test continues to be higher or lower than normal or urine sugar continues to be positive, indicating that diabetes is not properly controlled, doctors must be notified to maintain adequate insulin, and Syringes and needles, often wearing diabetes patient identification documents to ensure proper treatment when complications occur from home. 2. Any changes in insulin application must be taken care of and should be performed under the guidance of a doctor. Every time you use insulin, you should carefully check the purity, potency, registered trademark, type, species (bovine, pig, human), production method (recombinant human insulin, animal purified insulin) recommended by the doctor, any Changes in the above items will result in a change in dosage. 3. Patients who used animal insulin in the past were switching. Pregnancy and lactating women medication: Pregnancy can make diabetes more difficult to control, so women planning to conceive and pregnant or lactating women of childbearing age must consult a doctor. Pediatric Use: Children should pay attention to exercise and diet when using this medicine to better control blood sugar. When using, the injection should be performed by the parent or doctor at the dose adjusted by the doctor. Drugs for the elderly: In the course of insulin treatment, if the amount of insulin is too much, hypoglycemia may occur. Mild to moderate symptoms of hypoglycemia may occur suddenly, often with the following manifestations: sweating, drowsiness, dizziness Read more...

Common name: Adenosine triphosphate coenzyme for injection. Drug classification: Chemicals. Drug properties: prescription drugs. Related diseases: Heart failure, cirrhosis, nephritis. Main Ingredients: This product is a compound preparation, and its components each contain 20 mg of adenosine triphosphate, 50 units of coenzyme A, and 4 units of insulin. Indications: For the improvement of symptoms such as hepatitis, nephritis, cirrhosis, heart failure and other diseases. Specifications: adenosine triphosphate 20mg, coenzyme A50 units, insulin 4 units. Adverse reactions: Insulin in this product can cause local redness, itching, urticaria, angioedema. Dosage: Intravenous injection. Dilute with 25% glucose injection and slowly inject. Intravenous drip. After instillation with 500 ml of 5% glucose injection, the instillation was carried out. Intramuscular injection. After injecting 2 ml of sodium chloride injection, it was injected. One day, 2-6 weeks for a course of treatment. Contraindications: Disabled for people who are allergic to insulin. Note: 1, this product contains insulin, should not be used on an empty stomach, intravenous injection should be slow, otherwise it will cause heart palpitations, sweating and so on. 2, severe liver and kidney disease patients closely observe changes in blood sugar. 3. It is forbidden to use when the trait of the drug changes. Pregnancy and lactating women medication: Not yet clear. Pediatric Use: Not yet clear. Drugs for the elderly: It is not clear. Pharmacology and Toxicology: The sodium adenosine triphosphate in this product can improve the metabolism of the body, participate in the metabolism of fat proteins, sugars, nucleic acids and nucleotides in the body, and is also the source of energy in the body. Coenzyme A is a coenzyme that metabolizes acetylation in the body and plays an important role in the metabolism of sugar, fat and protein. It is closely related to the synthesis of acetylcholine in the body, the accumulation of hepatic glycogen, the decrease of cholesterol and the regulation of blood lipid content. Insulin lowers blood sugar, inhibits glycogen decomposition and gluconeogenesis, so that muscle and adipose tissue take up glucose and amino acids, and promotes the decomposition of very low-density lipoprotein. Storage: Store in a cool place (not to exceed 20 ° C).

Generic Name: 50/50 Mixed Recombinant Human Insulin Injection Product Name: Gan Shulin 50R Drug Category: Biological Products Drug Properties: Prescription Drug Related Diseases: Diabetic Traits: This product is a white or white-like sterile suspension liquid that can be evenly shaken after shaking dispersion. Main Ingredients: Active Ingredient: Recombinant Human Insulin Inactive Ingredients: Protamine sulfate, phenol, m-cresol, glycerol, disodium hydrogen phosphate indications: Type 1 or type 2 diabetes. Specifications: 3ML: 300IU Adverse reactions: Usage and dosage: How to use: 1. Check whether the refill is consistent with the doctor's recommended specifications before use. 2. Method of preparing insulin: According to the method of using Dongbao pen, after installing the refill correctly into the refill holder, install the Dongbao needle. Slowly invert the Dongbao pen 8-10 times to make the liquid in the refill mix evenly. Turn the dose adjustment knob to adjust to the desired dose. After removing the needle cap and inserting the air bubbles, you can inject it. Be careful not to touch the needle with anything during use to prevent contamination. 3. Selection of injection site: The injection site should choose the looser part of the skin, such as the arms, thighs, buttocks and abdomen, etc. The injection site should alternate in turn. The same part can not be injected continuously for two weeks within two weeks. The last injection site was about 1 cm apart. Taboo: Low blood sugar. Prohibition of insulin allergic reactions. Note: Pregnant women and lactating women medication: pregnancy can make diabetes more difficult to control, so pregnant women planning to conceive and pregnant or lactating women of childbearing age, must consult a doctor. Pediatric Use: Children should pay attention to exercise and diet when using this medicine to better control blood sugar. When using, the injection should be performed by the parent or doctor at the dose adjusted by the doctor. Drugs for the elderly: It is not clear. Drug Interactions: If you are taking oral contraceptives, adrenocortical hormones, thyroid hormones instead of treatments that cause high blood sugar, you must ask your doctor to increase the dose of insulin. If you are taking oral hypoglycemic agents, salicylic acid preparations, sulfonamides, and certain antidepressants that cause a drop in blood sugar, you must ask your doctor to reduce the dose of insulin. Pay attention to your diet and don't drink alcoholic beverages. Therefore, please consult your doctor when taking other medicines at the same time. Pharmacology and Toxicology: This product is human insulin produced by recombinant DNA technology and has the same structure and function as natural insulin. It can regulate glucose metabolism, promote the uptake and utilization of glucose by liver, bone and adipose tissue, promote the conversion of glucose into glycogen and store it in muscle and liver, and inhibit gluconeogenesis, thereby lowering blood sugar. Pharmacokinetics: This product is injected subcutaneously. Because of the difference in the onset and duration of individual differences, the drug usually takes effect 30 minutes after injection and reaches a peak in 2-8 hours for 24 hours. Storage: This product should be stored in a refrigerator at 2-8 °C before use. The refills stored in the insulin injection pen should not be stored in the refrigerator. The patient can carry one under the condition of avoiding direct sunlight or hot drama. month. Validity: 24 months

Generic Name: 30/70 Mixed Recombinant Human Insulin Injection Product Name: Gan Shulin 30R Drug Category: Biological Products Drug Properties: Prescription Drug Related Diseases: Diabetic Properties: This product is a white or white-like sterile suspension liquid that can be evenly dispersed. The pH range of this product is between 7.0 and 7.8. Ingredients: Active Ingredients: Recombinant Human Insulin; Inactive Ingredients: Protamine sulfate, phenol, m-cresol, glycerol, disodium hydrogen phosphate, zinc oxide indications: Type I or Type II diabetes. Specifications: 3ml: 300IU Adverse reactions: Hypoglycemia is the most frequent adverse reaction in insulin therapy, and symptoms of hypoglycemia often appear suddenly. The literature reported occasional injection of local redness, itching and other allergic reactions and local subcutaneous lipid hyperplasia. Systemic allergic reactions (systemic rash, shortness of breath, asthma, decreased blood pressure, accelerated pulse, hyperhidrosis, severe cases can be life-threatening) are rarely reported. 1. Lipid dystrophy: Subcutaneous injection of insulin rarely causes lipid atrophy or lipid hyperplasia. If this happens, you must tell your doctor that changing the injection technique may improve it. 2. Insulin allergy: 1 Local allergic reaction: The patient occasionally has red and swollen injection site, which is called local allergy. It usually disappears within a few days or weeks. In some cases, it may be caused by other causes and insulin dosage. How to use: 1. Check if the refill is consistent with the doctor's recommended specifications before use. 2. Method of preparing insulin: According to the method of using Dongbao pen, correctly insert the refill into the refill holder, and then install the Dongbao needle. Slowly invert the Dongbao pen 8 to 10 times to make the liquid in the refill mix evenly. Turn the dose adjustment knob to adjust to the desired dose. After removing the needle cap and draining the air bubbles, you can inject it. Be careful not to touch the needle with anything during use to prevent contamination. 3. Selection of injection site: The injection site should choose the looser part of the skin, such as the upper arm, thigh, buttocks and abdomen. The injection site should alternate in turn. The same site can not be injected twice in two weeks. Each injection site should be The last injection site was about 1 cm apart. Contraindications: Prohibition of insulin allergic reactions. Precautions: 1. People with diabetes should check their blood sugar or urine sugar regularly. If the blood glucose test continues to be higher or lower than normal or the urine sugar continues to be positive, indicating that diabetes is not properly controlled, the doctor must be notified. Always keep enough insulin, as well as syringes and needles, often wear a Diabetic Identification Document to ensure proper treatment when complications occur from home. 2. Any changes in insulin application must be taken care of under the guidance of a doctor. Before using insulin, you should carefully check the purity, potency, registered trademark, type, species (bovine, pig, human) of insulin. Whether the production method (recombinant human insulin, animal-purified insulin) is recommended by the doctor, any change will result in a change in dosage. Pregnancy and lactating women medication: Pregnancy can make diabetes more difficult to control, so women planning to conceive and pregnant or lactating women of childbearing age must consult a doctor. Pediatric Use: Children should pay attention to exercise and diet when using this medicine to better control blood sugar. When using, the injection should be performed by the parent or doctor at the dose adjusted by the doctor. Drugs for the elderly: Not clear. Drug Interactions: If you are taking medications that cause elevated blood sugar, such as oral contraceptives, adrenocortical hormones, and thyroid hormone replacement therapy, you must increase the dose of insulin. If you are taking oral hypoglycemic agents, salicylic acid preparations, sulfonamides, and certain antidepressants that cause blood sugar lowering, you must reduce the dose of insulin. Pay attention to your diet and don't drink alcoholic beverages. Therefore, please consult your doctor when taking other medicines at the same time. Pharmacology and Toxicology: This product is human insulin produced by recombinant DNA technology and has the same structure and function as natural insulin. It can regulate glucose metabolism, promote the uptake and utilization of glucose by liver, bone and adipose tissue, promote the conversion of glucose into glycogen and store it in muscle and liver, and inhibit gluconeogenesis, thereby lowering blood sugar. Pharmacokinetics: The subcutaneous injection of this product has a large difference in the onset and duration of the drug due to individual differences. It usually takes effect 30 minutes after injection and reaches a peak in 2 to 8 hours, lasting about 24 hours. Storage: This product should be stored in a refrigerator at 2 ~ 8 ° C before use, do not freeze or close to the ice tray, frozen insulin can not be used, the refill stored in the insulin injection pen should not be stored in the refrigerator, the patient can Carry it with you for a month without being exposed to direct sunlight or hot drama. Validity: 30 months

Generic Name: Recombinant Glycerin Injection Product Name: Chang Xiulin Drug Classification: Biological Products Drug Properties: Prescription Drug Related Diseases: Main components of diabetes: 1. Insulin glargine. 2. Other ingredients: zinc chloride, m-cresol, glycerin, sodium hydroxide, hydrochloric acid, water for injection. Indications: This product is suitable for diabetes. Specifications: 100 units / ml × 10ml × 1 bottle. Adverse reactions: 1. Hypoglycemia: Hypoglycemia is generally caused by improper selection of insulin dosage forms, excessive dosage or/inconsistent with dietary movements. 2. Fat malnutrition: If the injection site is not frequently rotated, it may cause fat atrophy or lipid hyperplasia at the injection site. 3. Allergic reactions: Local allergic reactions may occur during insulin therapy, such as redness, pain, itching, urticaria, swelling or inflammation at the injection site. These reactions are usually mild, temporary and will disappear during continued treatment. Systemic allergic reactions are rare and can be life threatening. 4. Eyes: Temporary visual impairment may occur when blood glucose control changes significantly. Due to intensive insulin therapy, glycemic control is rapidly improved, and diabetic retinopathy may be temporarily deteriorated. Usage and dosage: 1. Usage. 2. Insulin glargine has a long-acting effect, and can be injected subcutaneously once a day. 3. Insulin glargine should be administered subcutaneously and return to room temperature before injection. Follow the steps below when injecting. (1) Observe the appearance of the liquid in the bottle. Normally it should be a colorless clear solution. Do not continue to use if the appearance is cloudy, slight color changes, or visible particles. (2) Remove the plastic protective cap before using the new drug, but do not remove the stopper. Wipe the top of the bottle and the stopper with a 75% alcohol cotton ball before each use. (3) Draw the same amount of air as you need insulin glargine, insert the needle into the stopper and inject the air into the needle. (4) Hold the vial upside down with one hand. (5) Make sure the needle of the syringe is below the liquid level and extract the correct agent. Contraindications: 1. Low blood sugar. 2. Those who are allergic to insulin glargine or other ingredients in the injection. Read more...

Generic Name: Protamine Zinc Recombinant Human Insulin Mixture Product Name: Subtelin Drug Category: Biological Related Diseases: Diabetes, Main Ingredients: The active ingredient of this product is: recombinant human insulin. Indications: This product is mainly used to treat type I or type II diabetes. Specifications: 400 units / 10ml / bottle of adverse reactions: The literature reported occasional injection of local redness, itching and other allergies should be local subcutaneous lipid proliferation. Systemic allergic reactions (systemic rash, shortness of breath, asthma, decreased blood pressure, rapid pulse, hyperhidrosis, severe life-threatening cases) are rarely reported. 1. Lipid dystrophy, subcutaneous injection of insulin rarely causes lipid atrophy or lipid proliferation. If this happens, you must inform your doctor. Changing injection techniques may improve this. 2. Insulin allergy (1) Local allergic reactions. Occasionally, the patient's injection site is red and swollen, which is called local allergy. It usually disappears within a few days or weeks. In some cases, it may be caused by other causes and has nothing to do with insulin injection. If the skin disinfectant is irritated, the injection technique is not good, etc., if a local reaction occurs, immediately inform the doctor. Dosage: The clinician determines the therapeutic dose of insulin administered to the patient based on the actual needs of the patient. It should be administered by subcutaneous injection, although it is not recommended but can also be administered intramuscularly. It can not be administered by intravenous injection. The upper arm, thigh, buttocks or abdomen should be selected for subcutaneous injection. At the same time, attention should be paid to the rotation of the injection site. The number of injections per month for the same site should not exceed one. Care should be taken during injections to ensure that blood vessels are not pierced. When the injection is completed, the injection site cannot be sputum. Patients should be aware of the correct method of administration by injection. a) The preparation of the dose should be inverted 10 times in the hand and 10 times in the 180° before use to ensure that the insulin preparation shows a uniform turbid or milky state at the time of injection. Contraindications: Those with a history of insulin allergy are banned. Precautions: 1. Diabetes patients should check blood sugar or urine sugar regularly. If blood glucose test continues to be higher or lower than normal or urine sugar continues to be positive, indicating that diabetes is not properly controlled, doctors must be notified to maintain adequate insulin, and Syringes and needles, often wearing diabetes patient identification documents to ensure proper treatment when complications occur from home. 2. Any changes in insulin application must be taken care of and should be performed under the guidance of a doctor. Every time you use insulin, you should carefully check the purity, potency, registered trademark, type, species (bovine, pig, human), production method (recombinant human insulin, animal purified insulin) recommended by the doctor, any Changes in the above items will result in a change in dosage. 3. In the past, patients who used animal insulin were switched to pregnant women and lactating women. Pregnancy made diabetes more difficult to control. Therefore, pregnant women who are planning to become pregnant and pregnant or breastfeeding must consult a doctor. Pediatric Use: Children should pay attention to exercise and diet when using this medicine to better control blood sugar. When using, the injection should be performed by the parent or doctor at the dose adjusted by the doctor. Drugs for the elderly: In the course of insulin treatment, if the amount of insulin is too much, hypoglycemia may occur. Mild to moderate symptoms of hypoglycemia may occur suddenly, often with the following manifestations: sweating, lethargy, dizziness, insomnia, palpitations, anxiety, trembling, blurred vision, hunger Read more...

Generic Name: Conventional Recombinant Human Insulin Injection Product Name: Conventional Utilin Drug Category: Chemical Manufacturer: Lilly France SA Drug Properties: Prescription Drug Related Diseases: Diabetes, Early Diabetes, Gestational Diabetes Traits: Injectable Ingredients: Recombinant Human Insulin . Indications: This product is suitable for the treatment of diabetic patients who need insulin to maintain blood sugar levels. It is also suitable for early treatment of early diabetic patients and for the treatment of diabetic patients during pregnancy. Specifications: 300 units / 3ml / pen adverse reactions: The literature reported occasional injection of local redness, itching and other allergic reactions and local subcutaneous lipid proliferation. Systemic allergic reactions (systemic rash, shortness of breath, asthma, decreased blood pressure, accelerated pulse, excessive sweating, and severely punishing cases can be life-threatening) are rarely reported. 1. Lipid dystrophy: Subcutaneous injection of insulin rarely causes lipid atrophy or lipid proliferation. If this happens, you must tell your doctor that changing the injection technique may improve it. 2. Insulin allergy: (1) local allergic reactions. Occasionally, the patient's injection site is red and swollen, which is called local allergy. It usually disappears within a few days or weeks. In some cases, it may be caused by other causes and has nothing to do with insulin injection. Such as skin disinfectant stimulation, poor injection technology, etc., if a local reaction occurs, usage and dosage: 1. This product is a white suspension, subcutaneous injection about 1 hour before breakfast and dinner, the specific time is determined by the doctor according to the condition. 2. Method of using insulin: Be careful not to touch the needle number with any object during use to prevent contamination. If it is to be mixed with recombinant human insulin injection, it should be carried out under the guidance of a doctor. Before extracting recombinant human insulin, the vial should be placed in the palm of the hand and gently rolled until the insulin is in a uniform suspension. The same amount of low-protamine recombinant human insulin is extracted with a syringe, and the air is injected into the reconstitution. Inside the human insulin bottle, then pull the needle out. The same amount of air as the conventional recombinant human insulin is injected with a syringe, and the air is injected into a conventional recombinant human insulin bottle, and then the vial and the syringe are inverted. Contraindications: Those with a history of insulin allergy are banned. Note: 1. Diabetic patients should check blood sugar or urine sugar regularly. If the blood glucose test continues to be higher or lower than normal or urine sugar continues to be positive, indicating that diabetes is not properly controlled, the doctor must be notified. Always keep enough insulin and syringes and needles, often wearing diabetes patient identification documents to ensure proper treatment when complications occur from home. 2. Any changes in insulin application must be taken care of and should be performed under the guidance of a doctor. Every time you use insulin, you should carefully check the purity, potency, registered trademark, type, species (bovine, pig, human), production method (recombinant human insulin, animal purified insulin) recommended by the doctor, any A change in the term will result in a change in dosage. Pregnancy and lactating women medication: Pregnancy can make diabetes more difficult to control, so women planning to conceive and pregnant or lactating women of childbearing age must consult a doctor. Pediatric Use: 1. Children should pay attention to exercise and diet when using this medicine, in order to better control blood sugar. 2. When using, the injection should be performed by the parent or doctor according to the dose adjusted by the doctor. Drugs for the elderly: 1. In the course of insulin treatment, if the amount of insulin is too much, hypoglycemia may occur. Mild to moderate symptoms of hypoglycemia may occur suddenly, often with the following manifestations: sweating, lethargy; dizziness, insomnia; palpitations, anxiety; trembling, blurred vision; hunger, ambiguous pronunciation; powerlessness, depression; hands, feet, Tongue and lip stings are prone to anger; dizziness, abnormal behavior; lack of concentration, unstable behavior; headache, personality changes; symptoms of severe hypoglycemia are as follows: disorientation, epilepsy; loss of consciousness, death. 2. It is very important to get timely treatment when hypoglycemia occurs. In some cases, early hypoglycemia symptoms are not readily detectable, such as chronic diabetes patients, diabetic patients with neuropathy, diabetic patients with beta blockers, and insulin replacement. Drug interactions: 1. Oral contraceptives, adrenocortical hormones, thyroid hormone replacement therapy, etc. can cause high blood sugar, while increasing the dose of insulin. 2. Oral hypoglycemic agents, salicylic acid preparations, sulfonamides and certain antidepressants can cause blood sugar to drop. At the same time, the application should reduce the dose of insulin. 3. Avoid drinking alcoholic beverages. Pharmacology and Toxicology: This product is human insulin produced by recombinant DNA technology and has the same structure and function as natural insulin. It can regulate glucose metabolism, promote the uptake and utilization of glucose by liver, bone and adipose tissue, promote the conversion of glucose into glycogen and store it in muscle and liver, and inhibit gluconeogenesis, thereby lowering blood sugar. Read more...